A Systematic Review of the Role of Penile Rehabilitation in Prostate Cancer Patients Receiving Radiotherapy and Androgen Deprivation Therapy

被引:5
|
作者
Doherty, Wesley [1 ]
Bridge, Pete [2 ]
机构
[1] Christie Hosp NHS Trust, Radiotherapy Dept, Manchester, Lancs, England
[2] Univ Liverpool, Directorate Radiotherapy, Liverpool, Merseyside, England
关键词
Prostate; radiotherapy; erectile dysfunction; penile rehabilitation; ERECTILE FUNCTION IIEF; QUALITY-OF-LIFE; SILDENAFIL CITRATE; RADIATION-THERAPY; DOUBLE-BLIND; PHOSPHODIESTERASE-5; INHIBITORS; RADICAL RADIOTHERAPY; INTERNATIONAL INDEX; OPEN-LABEL; DYSFUNCTION;
D O I
10.1016/j.jmir.2018.09.004
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction/Background: Treatment-induced erectile dysfunction (ED) is a common side effect of radiotherapy and androgen deprivation therapy (ADT) that impacts on patient quality of life. Penile rehabilitation interventions including pharmacologic and physical therapies aim to reduce the impact of ED. Despite The National Institute for Health and Care Excellence guidelines recommending access to ED services, penile rehabilitation is not widely discussed or implemented. This systematic review aimed to appraise the evidence base for penile rehabilitation and identify evidence-based recommendations for practice. Methods: A systematic review of the evidence base was undertaken using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The Scopus and Medline (EBSCO) databases were searched for articles relevant to penile rehabilitation interventions for prostate radiotherapy patients. Study quality was graded using the Oxford Levels of Evidence and the Scottish Intercollegiate Guidelines Network. Results: This study identified 19 articles on penile rehabilitation in prostate radiotherapy patients, consisting of eight randomized controlled trials, three systematic reviews, and eight case studies. Findings confirmed the value of early use of phosphodiesterase type 5 inhibitors. Discussion: Despite the range of available physical and pharmaceutical interventions, relevant research focussed solely on the use of phosphodiesterase type 5 inhibitors. Themes from the reviewed articles indicated that timing of intervention was important with early on-going dosage most useful. There was also an identified need for ongoing prophylactic use during ADT. Evidence, in general, was of low quality and based on quantitative data only. Conclusion: Additional research into the wider range of penile rehabilitation interventions is urgently required to ensure patients have access to those therapies that are most appropriate for them. A paradigm shift toward qualitative research in the field of penile rehabilitation for prostate cancer patients treated with radiotherapy and ADT may be of value in future studies.
引用
收藏
页码:171 / 178
页数:8
相关论文
共 50 条
  • [1] Development of UK guidance on the management of erectile dysfunction resulting from radical radiotherapy and androgen deprivation therapy for prostate cancer
    White, I. D.
    Wilson, J.
    Aslet, P.
    Baxter, A. B.
    Birtle, A.
    Challacombe, B.
    Coe, J.
    Grover, L.
    Payne, H.
    Russell, S.
    Sangar, V.
    Van As, N.
    Kirby, M.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2015, 69 (01) : 106 - 123
  • [2] Androgen Deprivation Therapy and Definitive Radiotherapy for Prostate Cancer
    Mendenhall, William M.
    Henderson, Randal H.
    Hoppe, Bradford S.
    Nichols, Romaine Charles
    Mendenhall, Nancy P.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (05): : 530 - 534
  • [3] Impact of Androgen Deprivation Therapy on Sexual and Hormonal Function in Patients Receiving Radiation Therapy for Prostate Cancer
    Kushnir, Tamara
    Gofrit, Ofer N.
    Elkayam, Ruth
    Paluch-Shimon, Shani
    Lawrence, Yaacov R.
    Weiss, Ilana
    Symon, Zvi
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2016, 18 (01): : 49 - 53
  • [4] Radical prostatectomy versus external beam radiotherapy with androgen deprivation therapy for high-risk prostate cancer: a systematic review
    Heesterman, Berdine L.
    Aben, Katja K. H.
    de Jong, Igle Jan
    Pos, Floris J.
    van der Hel, Olga L.
    BMC CANCER, 2023, 23 (01)
  • [5] The Effects of Statins on Prostate Cancer Patients Receiving Androgen Deprivation Therapy or Definitive Therapy: A Systematic Review and Meta-Analysis
    Hou, Yu-Chen
    Shao, Yu-Hsuan
    PHARMACEUTICALS, 2022, 15 (02)
  • [6] Combination of radiotherapy and androgen deprivation therapy for localized prostate cancer
    Hennequin, C.
    Fumagalli, I.
    Martin, V.
    Quero, L.
    CANCER RADIOTHERAPIE, 2017, 21 (6-7): : 462 - 468
  • [7] Assessment and predictors of fatigue in men with prostate cancer receiving radiotherapy and androgen deprivation therapy
    Bandara, Vindya
    Capp, Anne
    Ahmed, Gias
    Arm, Jameen
    Martin, Jarad
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2019, 63 (05) : 683 - 690
  • [8] Physical exercise for bone health in men with prostate cancer receiving androgen deprivation therapy: a systematic review
    Bressi, Barbara
    Cagliari, Maribel
    Contesini, Massimiliano
    Mazzini, Elisa
    Bergamaschi, Franco Antonio Mario
    Moscato, Alfredo
    Bassi, Maria Chiara
    Costi, Stefania
    SUPPORTIVE CARE IN CANCER, 2021, 29 (04) : 1811 - 1824
  • [9] Contemporary Role of Androgen Deprivation Therapy for Prostate Cancer
    Pagliarulo, Vincenzo
    Bracarda, Sergio
    Eisenberger, Mario A.
    Mottet, Nicolas
    Schroeder, Fritz H.
    Sternberg, Cora N.
    Studer, Urs E.
    EUROPEAN UROLOGY, 2012, 61 (01) : 11 - 25
  • [10] Androgen Deprivation Therapy Combined With Particle Therapy for Prostate Cancer: A Systematic Review
    Petersen, Stine Elleberg
    Hoyer, Morten
    FRONTIERS IN ONCOLOGY, 2021, 11